7.88
price down icon1.38%   -0.10
 
loading
Precedente Chiudi:
$7.98
Aprire:
$8.08
Volume 24 ore:
38,919
Relative Volume:
0.06
Capitalizzazione di mercato:
$921.95M
Reddito:
-
Utile/perdita netta:
$-174.61M
Rapporto P/E:
-3.7346
EPS:
-2.11
Flusso di cassa netto:
$-165.54M
1 W Prestazione:
-10.06%
1M Prestazione:
-3.20%
6M Prestazione:
-12.07%
1 anno Prestazione:
+3.69%
Intervallo 1D:
Value
$7.80
$8.0992
Intervallo di 1 settimana:
Value
$7.675
$8.85
Portata 52W:
Value
$7.00
$16.63

89 Bio Inc Stock (ETNB) Company Profile

Name
Nome
89 Bio Inc
Name
Telefono
(415) 432-9270
Name
Indirizzo
142 SANSOME STREET, SAN FRANCISCO, CA
Name
Dipendente
70
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-07
Name
Ultimi documenti SEC
Name
ETNB's Discussions on Twitter

Confronta ETNB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ETNB 7.89 921.95M 0 -174.61M -165.54M -2.11
VRTX 446.52 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.51 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 592.50 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.90 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.19 24.49B 3.30B -501.07M 1.03B 11.54

89 Bio Inc Stock (ETNB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-05-12 Aggiornamento Raymond James Outperform → Strong Buy
2021-12-20 Iniziato H.C. Wainwright Buy
2021-10-26 Ripresa Cantor Fitzgerald Overweight
2021-07-29 Ripresa BTIG Research Buy
2021-05-25 Downgrade Raymond James Strong Buy → Outperform
2021-04-21 Iniziato Cantor Fitzgerald Overweight
2020-10-19 Iniziato Raymond James Strong Buy
2020-09-25 Aggiornamento BofA Securities Neutral → Buy
2020-07-31 Iniziato Piper Sandler Overweight
2020-07-23 Iniziato BTIG Research Buy
2020-07-07 Iniziato Chardan Capital Markets Buy
2019-12-09 Iniziato BofA/Merrill Neutral
2019-12-09 Iniziato Oppenheimer Outperform
2019-12-09 Iniziato RBC Capital Mkts Outperform
2019-12-09 Iniziato SVB Leerink Outperform
Mostra tutto

89 Bio Inc Borsa (ETNB) Ultime notizie

pulisher
Nov 20, 2024

89Bio Inc. Reports Q3 2024 Financial Results - TipRanks

Nov 20, 2024
pulisher
Nov 19, 2024

RA CAPITAL MANAGEMENT, L.P. Increases Stake in 89bio Inc - GuruFocus.com

Nov 19, 2024
pulisher
Nov 18, 2024

89bio Inc.’s $125 Million Common Stock Offering - Global Legal Chronicle

Nov 18, 2024
pulisher
Nov 15, 2024

Syncona building Slingshot incubator; Trace launches with $101M - BioCentury

Nov 15, 2024
pulisher
Nov 15, 2024

89bio reports potential MASH treatment progress By Investing.com - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

89bio reports potential MASH treatment progress - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

89bio's Pegozafermin Shows Promising Results in Advanced MASH Treatment Trial | ETNB Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 14, 2024

89bio, Inc. announces public offering and warrant issuance - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Janus Henderson Group PLC's Strategic Acquisition in 89bio Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

FY2024 EPS Estimates for 89bio Lowered by Cantor Fitzgerald - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

HC Wainwright Issues Pessimistic Estimate for 89bio Earnings - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

89bio announces $100 million public stock offering - Investing.com India

Nov 14, 2024
pulisher
Nov 13, 2024

SEC Form 424B5 filed by 89bio Inc. - Quantisnow

Nov 13, 2024
pulisher
Nov 13, 2024

89bio drops 2%, prices $125M stock offering - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

89bio announces $100 million public stock offering By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

89bio Raises $125M in Upsized Public Offering at $8.50 Per Share | ETNB Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire Inc.

Nov 12, 2024
pulisher
Nov 12, 2024

ETNB89bio, Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

89bio announces proposed underwritten public offering of common stock and pre-funded warrants - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

BioLife Solutions Surges 30% in Q3 Revenue, Slashes Net Loss by 89% | Earnings Report | BLFS Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

89bio Launches $100M Public Offering to Advance Pegozafermin Development | ETNB | ETNB Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

GLP-1s push into MASH as semaglutide 2.4 mg hits endpoints - BioWorld Online

Nov 12, 2024
pulisher
Nov 12, 2024

89bio Inc (ETNB) Quarterly 10-Q Report - Quartzy

Nov 12, 2024
pulisher
Nov 12, 2024

89bio, Inc. (NASDAQ:ETNB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

HC Wainwright Reaffirms Buy Rating for 89bio (NASDAQ:ETNB) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

FY2028 Earnings Estimate for 89bio Issued By Leerink Partnrs - MarketBeat

Nov 11, 2024
pulisher
Nov 08, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Nov 08, 2024
pulisher
Nov 08, 2024

Raymond James Issues Pessimistic Forecast for 89bio (NASDAQ:ETNB) Stock Price - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

89bio Reports Third Quarter 2024 Financial Results and Corporate UpdatesSAN FRANCISCO, November 7, 2024 (GLOBE NEWSWIRE) – On November 7, 2024, 89bio, Inc. (NASDAQ: ETNB), a clinical-stage biopharmaceutical company focusing on innovativ - Defense World

Nov 08, 2024
pulisher
Nov 07, 2024

89bio Reports Third Quarter 2024 Financial Results and Corporate Updates - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

89bio Inc (ETNB) Has A Gold Mine On Its Hands - Stocks Register

Nov 07, 2024
pulisher
Nov 07, 2024

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update - BioSpace

Nov 07, 2024
pulisher
Nov 06, 2024

Harbor Capital Advisors Inc. Purchases 142,032 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

89bio to Participate in the UBS Global Healthcare Conference - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

89bio to Present at UBS Global Healthcare Conference: Key Investor Updates Coming | ETNB Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Lyft Inc Cl A (LYFT-Q) QuotePress Release - The Globe and Mail

Nov 05, 2024
pulisher
Nov 05, 2024

UBS Group Ag ADR (UBS-N) QuotePress Release - The Globe and Mail

Nov 05, 2024
pulisher
Nov 04, 2024

89bio (NASDAQ:ETNB) Shares Gap DownHere's What Happened - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Block Inc (SQ-N) QuotePress Release - The Globe and Mail

Nov 04, 2024
pulisher
Nov 02, 2024

Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH - Yahoo Finance

Nov 02, 2024
pulisher
Nov 01, 2024

89bio's chief technical operations officer sells $226,994 in stock - Investing.com India

Nov 01, 2024
pulisher
Nov 01, 2024

89bio's chief technical operations officer sells $226,994 in stock By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

89bio (NASDAQ:ETNB) Trading 7.3% HigherStill a Buy? - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Coinbase Global Inc Cl A (COIN-Q) QuotePress Release - The Globe and Mail

Oct 31, 2024
pulisher
Oct 30, 2024

Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail

Oct 30, 2024
pulisher
Oct 29, 2024

89Bio: Surviving A Competitive SpaceFor Now (NASDAQ:ETNB) - Seeking Alpha

Oct 29, 2024
pulisher
Oct 28, 2024

Global Severe Hypertriglyceridemia (SHTG) Treatment Market Set to Reach USD 2675.37 Million by 2033 - PharmiWeb.com

Oct 28, 2024
pulisher
Oct 28, 2024

Bank of America Corp (BAC-N) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 25, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Oct 25, 2024

89 Bio Inc Azioni (ETNB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):